GoalVest Advisory’s First Trust Health Care AlphaDEX Fund FXH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$480K Sell
3,925
-178
-4% -$20.4K 0.09% 85
2026
Q1
$450K Sell
4,103
-280
-6% -$31.8K 0.09% 105
2025
Q4
$499K Hold
4,383
0.1% 102
2025
Q3
$481K Hold
4,383
0.1% 95
2025
Q2
$454K Hold
4,383
0.11% 87
2025
Q1
$454K Hold
4,383
0.12% 86
2024
Q4
$456K Hold
4,383
0.13% 89
2024
Q3
$490K Hold
4,383
0.14% 82
2024
Q2
$458K Hold
4,383
0.15% 79
2024
Q1
$480K Buy
+4,383
New +$463K 0.16% 77

Other funds holding FXH

GoalVest Advisory's FXH Position: Q2 2026 in Review

GoalVest Advisory reduced its First Trust Health Care AlphaDEX Fund (FXH) stake by 4.3% in Q2 2026, selling an estimated $20.4K and leaving 3,925 shares worth $480K. The position accounts for 0.09% of the portfolio, ranked #85.

GoalVest Advisory first reported a position in FXH in Q1 2024 and has held it in 10 quarters since. The position peaked at $499K in Q4 2025. 252 funds tracked by Wall St. Rank hold FXH as of Q2 2026.

  • GoalVest Advisory held 3,925 shares of First Trust Health Care AlphaDEX Fund worth $480K as of Q2 2026.
  • GoalVest Advisory sold 178 First Trust Health Care AlphaDEX Fund shares in Q2 2026, an estimated $20.4K.
  • First Trust Health Care AlphaDEX Fund made up 0.09% of GoalVest Advisory's portfolio in Q2 2026, its #85 holding.
  • GoalVest Advisory first reported a position in First Trust Health Care AlphaDEX Fund in Q1 2024 and has held it in 10 quarters since.
  • GoalVest Advisory's First Trust Health Care AlphaDEX Fund position peaked at $499K in Q4 2025.
  • 252 funds tracked by Wall St. Rank held First Trust Health Care AlphaDEX Fund as of Q2 2026.

Based on GoalVest Advisory's 13F filing for Q2 2026, filed 9 Jul 2026.